Product Images Otulfi

This is a part of a medical device associated with a plunger and a needle guard for safe administration. It also includes activation clips and head wings for efficient operation. The text seems to be related to a medical injection device.*

This text contains information about ustekinumab-aauz, an injection for subcutaneous use, stored in a refrigerator between 36°F to 46°F. It comes in a single-dose prefilled syringe that should be discarded after use. The active ingredient is 45 mg/0.5 mL of ustekinumab-aauz. It also provides details on inactive ingredients and instructions on storage and handling. For dosage information, please refer to the prescribing information.*

This is a single-dose prefilled syringe with the National Drug Code (NDC) 65219-824-01. It is advised to discard any unused portion and store the syringe at 36°F to 46°F (2°C to 8°C), away from light, and without shaking. Freezing is not recommended. This syringe is for subcutaneous use. The syringe also includes information on lot number and expiry date.*

This text is a detailed description of ustekinumab-aauz, an injection for subcutaneous use. It includes information on dosage, storage, manufacturer, and disposal of the single-dose prefilled syringe. The text also contains details about the active and inactive ingredients in the medication, as well as guidance on reporting side effects and contacting a doctor for medical advice.*

Single dose prefilled syringe with NDC 65219-826-26 is designed for subcutaneous use. The syringe should be stored at a cold temperature range of 36°F to 46°F to maintain its integrity. Users are advised to protect the injection from light and avoid shaking the syringe before use. The lot number and expiration date are mentioned on the packaging for reference.*

This is the detailed information about a medication with the NDC 65219-828-05. It is an intravenous infusion solution containing 130 mg of ustekinumab-aauz per 26 mL vial. The solution must be diluted before use and stored in a refrigerator at 36°F to 46°F. The medication includes both active and inactive ingredients. It is a sterile solution without preservatives. Patients should consult their doctor for medical advice and report any side effects to the FDA. The medication guide should be dispensed to each patient, and any unused portion should be discarded.*

This is a product label for a medical injection, specifically a single-dose vial of 130 mg/26 mL solution for intravenous infusion only. The medication should be stored in a refrigerator at 36°F to 46°F (2°C to 8°C), in the original carton, and protected from light. It is manufactured by Fresenius Kabi USA, LLC and is a product of the Netherlands. The dosage information should be obtained from the prescribing information. Unused portions of the medication should be discarded.*